AIHealthcare

Gestalt Diagnostics is a privately held healthcare technology company based in Spokane, Washington, focused on digital pathology and AI-enabled laboratory workflows. Its flagship PathFlow® platform is a cloud-based, vendor-neutral enterprise system that brings whole-slide images, patient and case data, collaboration tools, laboratory integrations, and AI outputs into one environment. The company also provides professional, education, research, and enterprise IT services. Its AI-related capabilities include support for image analysis and biomarker scoring, integration of third-party pathology algorithms, and workflow automation. Gestalt positions its products as tools that enhance pathologists’ expertise, improve collaboration and turnaround times, and support the transition from microscope- and paper-based pathology to scalable digital workflows. Publicly reported users and partners include BioReference Laboratories, MindPeak, Pramana, and DLS Pathology Services. The company is a private emerging player in digital pathology, competing and partnering within a market that includes platform, imaging, workflow, and pathology-AI vendors. It has publicly stated goals of expanding adoption, enhancing AI capabilities, and pursuing U.S. FDA clearance; no verified public valuation or market-share figure was identified.